Thermo Fisher Scientific
TMO
2,268 hedge funds and large institutions have $175B invested in Thermo Fisher Scientific in 2022 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 928 increasing their positions, 864 reducing their positions, and 102 closing their positions.
14% more first-time investments, than exits
New positions opened: 116 | Existing positions closed: 102
12% more call options, than puts
Call options by funds: $1.47B | Put options by funds: $1.31B
7% more repeat investments, than reductions
Existing positions increased: 928 | Existing positions reduced: 864
0.57% more ownership
Funds ownership: 87.66% → 88.24% (+0.57%)
1% less funds holding
Funds holding: 2,283 → 2,268 (-15)
6% less funds holding in top 10
Funds holding in top 10: 253 → 239 (-14)
6% less capital invested
Capital invested by funds: $186B → $175B (-$11.1B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
+$624M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$553M |
| 3 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
+$496M |
| 4 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
+$478M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$458M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.12B |
| 2 |
HSBC Holdings
London,
United Kingdom
|
-$767M |
| 3 |
NIMI
Natixis Investment Managers International
Paris,
France
|
-$368M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$337M |
| 5 |
Temasek Holdings
Singapore
|
-$317M |
TMO Hedge Fund Activity: Q3 2022 in Review
2,268 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2022, worth a combined $175B — down 6% from $186B a quarter earlier.
Buyers outnumbered sellers: 116 funds opened new TMO positions and 102 closed out — a net gain of 14 holders — while 928 added to existing stakes and 864 trimmed.
The largest buyer was Amundi, adding an estimated $624M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.12B.
- 2,268 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2022, down from 2,283 in Q2 2022.
- Funds reported $175B of Thermo Fisher Scientific stock for Q3 2022, down 6% quarter-over-quarter.
- 116 funds opened new Thermo Fisher Scientific positions in Q3 2022 and 102 closed out, a net change of +14 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2022 was Amundi, an estimated $624M added.
- The largest Thermo Fisher Scientific seller in Q3 2022 was T. Rowe Price Associates, an estimated $2.12B sold.
Based on aggregated 13F filings for Q3 2022.